• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

叶酸修饰的具有二氧化硅壳的 PEG-PLGA 纳米粒用于卡培他滨的控制和靶向递送。

Folate-decorated PEG-PLGA nanoparticles with silica shells for capecitabine controlled and targeted delivery.

机构信息

National Engineering Research Center for Tissue Restoration and Reconstruction, Guangzhou 510006, China; Guangdong Province Key Laboratory of Biomedical Engineering, South China University of Technology, Guangzhou 510006, China; School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510641, China.

School of Materials Science and Engineering, South China University of Technology, Guangzhou 510641, China; National Engineering Research Center for Tissue Restoration and Reconstruction, Guangzhou 510006, China; Guangdong Province Key Laboratory of Biomedical Engineering, South China University of Technology, Guangzhou 510006, China.

出版信息

Int J Pharm. 2014 Apr 10;464(1-2):225-33. doi: 10.1016/j.ijpharm.2013.12.047. Epub 2014 Jan 22.

DOI:10.1016/j.ijpharm.2013.12.047
PMID:24463073
Abstract

Di-block polymer of poly (lactic-co-glycolic acid)-poly (ethylene glycol) (PLGA-PEG) end-capped with capecitabine (CAP) at the hydrophobic domain and folate (FA) at hydrophilic domain were synthesized respectively. The products were extensively studied by nuclear magnetic resonance ((1)H NMR) and gel permeation chromatography (GPC) measurement. By using emulsion-solvent evaporation method, the two conjugates, drug CAP and tetramethoxysilane (TMOS) were mixed to form the CAP entrapped nanoparticles (NPs) with the FA moieties exposed on NPs surface, while simultaneously forming a cross-linked silica shell out of hydrophobic PLGA core domain. The testing results showed the CAP-loaded NPs presented suitable physical stability, favorable size around 200 nm, negative zeta potential charge (-28.43 ± 2.55 mV) and high encapsulation efficiency (69%). Both silica shell cross-linked drug-loaded NPs (SSCL NPs) and none silica shell cross-linked NPs (NSSCL NPs) provided an initial burst release and followed by a sustained two-stage release of the CAP. Straight lines approximate the steady-state for the two-stage release, and the K/K' of the two stages are 1.96304 and 1.78697 respectively suggesting the silica shell influenced the release of first stage significantly.

摘要

分别合成了以喜树碱(CAP)封端于疏水区、叶酸(FA)封端于亲水区的聚(乳酸-共-乙醇酸)-聚(乙二醇)二嵌段聚合物(PLGA-PEG)。通过核磁共振(1H NMR)和凝胶渗透色谱(GPC)测量对产物进行了广泛研究。通过乳液溶剂蒸发法,将两种缀合物,药物 CAP 和四甲氧基硅烷(TMOS)混合,在 NPs 表面暴露 FA 部分的同时,形成 CAP 包封的纳米颗粒(NPs),而同时形成疏水性 PLGA 核域外的交联硅壳。测试结果表明,载有 CAP 的 NPs 具有合适的物理稳定性、约 200nm 的理想尺寸、负的 ζ 电位(-28.43±2.55mV)和高包封效率(69%)。交联载药硅壳纳米颗粒(SSCL NPs)和非交联载药纳米颗粒(NSSCL NPs)都提供了初始突释,随后是 CAP 的持续两阶段释放。两条直线近似于两阶段释放的稳态,两个阶段的 K/K'分别为 1.96304 和 1.78697,表明硅壳显著影响了第一阶段的释放。

相似文献

1
Folate-decorated PEG-PLGA nanoparticles with silica shells for capecitabine controlled and targeted delivery.叶酸修饰的具有二氧化硅壳的 PEG-PLGA 纳米粒用于卡培他滨的控制和靶向递送。
Int J Pharm. 2014 Apr 10;464(1-2):225-33. doi: 10.1016/j.ijpharm.2013.12.047. Epub 2014 Jan 22.
2
Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.载硫酸长春新碱的叶酸修饰聚乳酸-羟基乙酸共聚物-聚乙二醇纳米粒增强人乳腺癌细胞摄取
Drug Dev Ind Pharm. 2011 Nov;37(11):1339-46. doi: 10.3109/03639045.2011.575162. Epub 2011 Apr 27.
3
Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.叶酸修饰且聚乙二醇化的聚乳酸-羟基乙酸共聚物纳米粒用于提高5-氟尿嘧啶的抗肿瘤活性
Int J Pharm. 2017 Jan 10;516(1-2):61-70. doi: 10.1016/j.ijpharm.2016.11.012. Epub 2016 Nov 5.
4
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.用于控释给药的聚乳酸-羟基乙酸共聚物-卵磷脂-聚乙二醇核壳纳米颗粒
Biomaterials. 2009 Mar;30(8):1627-34. doi: 10.1016/j.biomaterials.2008.12.013. Epub 2008 Dec 25.
5
Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.用于更昔洛韦立体异构二肽前药持续释放的基于纳米颗粒的局部眼用制剂。
Drug Deliv. 2016 Sep;23(7):2399-2409. doi: 10.3109/10717544.2014.996833. Epub 2015 Jan 7.
6
Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.用于抗肿瘤活性的叶酸锚定的沙奎那韦包封聚乳酸-羟基乙酸共聚物纳米粒的研制与表征
Drug Dev Ind Pharm. 2015;41(11):1888-901. doi: 10.3109/03639045.2015.1019355. Epub 2015 Mar 4.
7
Folate-conjugated β-cyclodextrin from click chemistry strategy and for tumor-targeted drug delivery.点击化学策略合成的叶酸偶联β-环糊精及其用于肿瘤靶向药物传递。
J Biomed Mater Res A. 2012 Sep;100(9):2441-9. doi: 10.1002/jbm.a.34169. Epub 2012 May 5.
8
Sustained release of PTX-incorporated nanoparticles synergized by burst release of DOX⋅HCl from thermosensitive modified PEG/PCL hydrogel to improve anti-tumor efficiency.通过盐酸多柔比星从热敏性改性聚乙二醇/聚己内酯水凝胶中的突释协同实现的载有紫杉醇纳米颗粒的持续释放,以提高抗肿瘤效率。
Eur J Pharm Sci. 2014 Oct 1;62:267-73. doi: 10.1016/j.ejps.2014.06.002. Epub 2014 Jun 12.
9
Size-dependent internalisation of folate-decorated nanoparticles via the pathways of clathrin and caveolae-mediated endocytosis in ARPE-19 cells.载叶酸纳米粒子通过网格蛋白和小窝蛋白介导的内吞作用在 ARPE-19 细胞中的尺寸依赖性内化。
J Pharm Pharmacol. 2014 Apr;66(4):564-73. doi: 10.1111/jphp.12134. Epub 2013 Aug 25.
10
Tailoring the properties of mPEG-PLLA nanoparticles for better encapsulation and tuned release of the hydrophilic anticancer drug.定制甲氧基聚乙二醇-聚乳酸纳米粒的性质以实现对亲水性抗癌药物更好的包封和调控释放。
Drug Deliv Transl Res. 2017 Jun;7(3):416-427. doi: 10.1007/s13346-017-0372-9.

引用本文的文献

1
An in Vitro Study on Anticancer Efficacy of Capecitabine- and Vorinostat-incorporated Self-nanoemulsions.卡培他滨和伏立诺他复合自纳米乳剂抗癌疗效的体外研究
J Biomed Phys Eng. 2025 Aug 1;15(4):353-368. doi: 10.31661/jbpe.v0i0.2405-1757. eCollection 2025 Aug.
2
Application of Polyglycolic Acid/Poly (Lactic-co-glycolic Acid) in Thread Embedding Acupuncture for Obesity: New Strategies and Challenges.聚乙醇酸/聚(乳酸-乙醇酸共聚物)在埋线针灸治疗肥胖症中的应用:新策略与挑战
Diabetes Metab Syndr Obes. 2025 Jul 5;18:2175-2189. doi: 10.2147/DMSO.S525783. eCollection 2025.
3
Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717.
通过树突状细胞激活增强细胞介导的免疫:包裹SR717的三 - 氨基半乳糖修饰的聚乳酸 - 羟基乙酸共聚物 - 聚乙二醇纳米颗粒的作用
Front Immunol. 2024 Dec 23;15:1490003. doi: 10.3389/fimmu.2024.1490003. eCollection 2024.
4
Environmentally Friendly Strategies for Formulating Vegetable Oil-Based Nanoparticles for Anticancer Medicine.用于制备抗癌药物的植物油基纳米颗粒的环保策略
Pharmaceutics. 2023 Jul 8;15(7):1908. doi: 10.3390/pharmaceutics15071908.
5
Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer.靶向治疗纳米颗粒:对抗癌症的巨大希望
J Drug Deliv. 2017;2017:9090325. doi: 10.1155/2017/9090325. Epub 2017 Dec 31.
6
Magnetic Cationic Amylose Nanoparticles Used to Deliver Survivin-Small Interfering RNA for Gene Therapy of Hepatocellular Carcinoma In Vitro.磁性阳离子直链淀粉纳米颗粒用于体外递送生存素小干扰RNA进行肝细胞癌基因治疗
Nanomaterials (Basel). 2017 May 11;7(5):110. doi: 10.3390/nano7050110.
7
Immune activity and biodistribution of polypeptide K237 and folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles radiolabeled with 99mTc.用99mTc标记的多肽K237与叶酸共轭的两亲性聚乙二醇-聚乳酸-羟基乙酸共聚物纳米颗粒的免疫活性和生物分布
Oncotarget. 2016 Nov 22;7(47):76635-76646. doi: 10.18632/oncotarget.12850.
8
Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol.负载紫丁香苷和羟基酪醇的甲氧基聚乙二醇-聚乳酸-羟基乙酸共聚物纳米粒的制备、体外及体内评价
J Mater Sci Mater Med. 2016 Feb;27(2):24. doi: 10.1007/s10856-015-5641-x. Epub 2015 Dec 24.
9
Curdlan-Conjugated PLGA Nanoparticles Possess Macrophage Stimulant Activity and Drug Delivery Capabilities.可德兰共轭聚乳酸-羟基乙酸共聚物纳米颗粒具有巨噬细胞刺激活性和药物递送能力。
Pharm Res. 2015 Aug;32(8):2713-26. doi: 10.1007/s11095-015-1655-9. Epub 2015 Feb 28.
10
Oral delivery of capsaicin using MPEG-PCL nanoparticles.使用聚乙二醇-聚己内酯纳米颗粒进行辣椒素的口服给药。
Acta Pharmacol Sin. 2015 Jan;36(1):139-48. doi: 10.1038/aps.2014.113. Epub 2014 Dec 1.